DRH1 – a novel blood-based HPV tumour marker-Reference-Cited by-同舟云学术

DRH1 – a novel blood-based HPV tumour marker

Published:2020-06 Issue: Volume:56 Page:102804
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Weiland Thomas^ORCID,Eckert Alexander,Tomazic Peter Valentin,Wolf Axel,Pondorfer Prisca,Vasicek Sarah,Graupp Matthias,Holzmeister Clemens,Moser Ulrich,Andrianakis Alexandros,Kangler Georg,Kiss Peter,Brcic Luka,Kappler Matthias,Wickenhauser Claudia,Haak Anja,Krüger Maximilian,Al-Nawas Bilal,Blatt Sebastian,Brockmeyer Norbert,Skaletz-Rorowski Adriane,Potthoff Anja,French Lars E.,Charnowski Sara,Reinholz Markus,Kaufmann Andreas M.,Thies Sarah,Lambrecht Hans-Georg,Seliger Barbara,Wild Dominik C.,Thurnher Dietmar

Funder

Federal Ministry of Education and Research

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference34 articles.

1. Classification of papillomaviruses;de Villiers;Virology,2004

2. Human papilloma virus molecular biology and disease association;Doorbar;Rev Med Virol,2015

3. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

4. HPV-associated head and neck cancer: a virus-related cancer epidemic – a review of epidemiology, biology, virus detection and issues in management;Marur;Lancet Oncol,2010

5. Human papillomavirus and rising oropharyngeal cancer incidence in the United States;Chaturvedi;J Clin Oncol,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of antibody subclasses IgA, IgM and IgG against HPV L1 in HPV-positive oropharyngeal squamous cell carcinoma patients: a pilot study;European Archives of Oto-Rhino-Laryngology;2024-03-05

2. CER818: A Highly Specific and Sensitive HPV L1 High‐Risk Serological Lateral Flow Rapid Test for Early Detection of Cervical Cancer and Its Precursor Lesions;Infectious Diseases in Obstetrics and Gynecology;2024-01

3. 3D Printing for Cancer Diagnosis: What Unique Advantages Are Gained?;ACS Materials Au;2023-08-28

4. Survival benefit for HPV+ OPSCC patients with dominant serum IgA over IgG antibodies against HPV16 L1;2023-06-26

5. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics;BMC Health Services Research;2023-03-10